Full-Time

Senior Director

Biostatistics

Posted on 4/30/2024

Alector

Alector

201-500 employees

Develops immuno-neurology therapies for neurodegenerative diseases

Biotechnology

Senior

Remote in USA

Required Skills
Communications
Requirements
  • Ph.D. in Statistics or related discipline with 10+ years, or MS with 15+ years of proven experience in the biotechnology or related industry
  • Rich experience and expertise in the drug development of CNS diseases
  • Strong Statistical technical skills
  • Deep hands-on operational experiences in Biostatistics deliverables
  • Good project and people management skills
  • Up to date knowledge of industry and regulatory developments in Neuroscience
  • Demonstrated innovative and flexible ability and mindset to work in a changing and demanding environment
  • Demonstrated strong leadership, project management, collaboration, communication, and organization skills
  • Advanced programming skills in SAS, R and other relevant statistical software solutions
  • Detailed knowledge of adaptive designs, Bayesian methodology, trial simulation, and complex modeling
Responsibilities
  • Lead compound Biostatistician for assigned projects
  • Define statistical strategy and ensure appropriate statistical methodologies are applied
  • Provide expert statistical input and consultancy to global clinical trials
  • Collaborate with internal and external collaborators in study design and analysis
  • Author and review critical documents
  • Support project team and clinical study team
  • Participate in FDA and other regulatory body interactions

Alector Therapeutics is an excellent workplace for those interested in contributing to cutting-edge therapies in the realm of neurodegenerative diseases. With a focus on immuno-neurology, the company leverages advanced biotechnological methods to pioneer treatments that harness the body’s own immune system for healing. Their robust pipeline of programs in clinical trials demonstrates a commitment to scientific excellence and leadership in addressing complex medical challenges.

Company Stage

IPO

Total Funding

$269.5M

Headquarters

South San Francisco, California

Founded

2013

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

6%